@inproceedings{inproceedings, title  = {{Phase 1 Cohort Expansion of Flotetuzumab, a CD123×CD3 Bispecific Dart® Protein in Patients with Relapsed/Refractory Acute Myeloid Leukemia (AML)}},

 publisher = {{American Society of Hematology}},

 url = {{https://doi.org/10.1182/blood-2018-99-117085 }},

 year = {{2018}},

 month = {{11}},

 author = {{Uy GL and Rettig MP and Vey N and Godwin J and Foster MC and Rizzieri DA and Arellano ML and Topp MS and Huls G and Jongen-Lavrencic M and Martinelli G et al}},

 doi = {{10.1182/blood-2018-99-117085}},

 volume = {{132}},

 journal = {{Blood}},

 issue = {{Supplement 1}},

 pages = {{764-764}},

 note = {{Accessed on 2026/02/25}}}